Connection
Catherine Klein to Topotecan
This is a "connection" page, showing publications Catherine Klein has written about Topotecan.
|
|
Connection Strength |
|
 |
|
 |
|
0.207 |
|
|
|
-
Klein CE, Tangen CM, Braun TJ, Hussain MH, Peereboom DM, Nichols CR, Rivkin SE, Dakhil SR, Crawford ED. SWOG-9510: evaluation of topotecan in hormone refractory prostate cancer: a Southwest Oncology Group study. Prostate. 2002 Sep 01; 52(4):264-8.
Score: 0.207